Cargando…
The Other Face of Insulin—Overdose and Its Effects
Insulin is the most effective glycemic-lowering drug, and for people suffering from type 1 diabetes it is a life-saving drug. Its self-dosing by patients may be associated with a higher risk of overdose, both accidental and deliberate. Insulin-induced hypoglycemia causes up to 100,000 emergency depa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955302/ https://www.ncbi.nlm.nih.gov/pubmed/35324747 http://dx.doi.org/10.3390/toxics10030123 |
_version_ | 1784676303676375040 |
---|---|
author | Rzepczyk, Szymon Dolińska-Kaczmarek, Klaudia Uruska, Aleksandra Żaba, Czesław |
author_facet | Rzepczyk, Szymon Dolińska-Kaczmarek, Klaudia Uruska, Aleksandra Żaba, Czesław |
author_sort | Rzepczyk, Szymon |
collection | PubMed |
description | Insulin is the most effective glycemic-lowering drug, and for people suffering from type 1 diabetes it is a life-saving drug. Its self-dosing by patients may be associated with a higher risk of overdose, both accidental and deliberate. Insulin-induced hypoglycemia causes up to 100,000 emergency department calls per year. Cases of suicide attempts using insulin have been described in the literature since its introduction into therapy, and one of the important factors in their occurrence is the very fact of chronic disease. Up to 90% of patients who go to toxicology wards overdose insulin consciously. Patients with diabetes are burdened with a 2–3 times higher risk of developing depression compared to the general population. For this reason, it is necessary to develop an effective system for detecting a predisposition to overdose, including the assessment of the first symptoms of depression in patients with diabetes. A key role is played by a risk-conscious therapeutic team, as well as education. Further post-mortem testing is also needed for material collection and storage, as well as standardization of analytical methods and interpretation of results, which would allow for more effective detection and analysis of intentional overdose—both by the patient and for criminal purposes. |
format | Online Article Text |
id | pubmed-8955302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89553022022-03-26 The Other Face of Insulin—Overdose and Its Effects Rzepczyk, Szymon Dolińska-Kaczmarek, Klaudia Uruska, Aleksandra Żaba, Czesław Toxics Review Insulin is the most effective glycemic-lowering drug, and for people suffering from type 1 diabetes it is a life-saving drug. Its self-dosing by patients may be associated with a higher risk of overdose, both accidental and deliberate. Insulin-induced hypoglycemia causes up to 100,000 emergency department calls per year. Cases of suicide attempts using insulin have been described in the literature since its introduction into therapy, and one of the important factors in their occurrence is the very fact of chronic disease. Up to 90% of patients who go to toxicology wards overdose insulin consciously. Patients with diabetes are burdened with a 2–3 times higher risk of developing depression compared to the general population. For this reason, it is necessary to develop an effective system for detecting a predisposition to overdose, including the assessment of the first symptoms of depression in patients with diabetes. A key role is played by a risk-conscious therapeutic team, as well as education. Further post-mortem testing is also needed for material collection and storage, as well as standardization of analytical methods and interpretation of results, which would allow for more effective detection and analysis of intentional overdose—both by the patient and for criminal purposes. MDPI 2022-03-03 /pmc/articles/PMC8955302/ /pubmed/35324747 http://dx.doi.org/10.3390/toxics10030123 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rzepczyk, Szymon Dolińska-Kaczmarek, Klaudia Uruska, Aleksandra Żaba, Czesław The Other Face of Insulin—Overdose and Its Effects |
title | The Other Face of Insulin—Overdose and Its Effects |
title_full | The Other Face of Insulin—Overdose and Its Effects |
title_fullStr | The Other Face of Insulin—Overdose and Its Effects |
title_full_unstemmed | The Other Face of Insulin—Overdose and Its Effects |
title_short | The Other Face of Insulin—Overdose and Its Effects |
title_sort | other face of insulin—overdose and its effects |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955302/ https://www.ncbi.nlm.nih.gov/pubmed/35324747 http://dx.doi.org/10.3390/toxics10030123 |
work_keys_str_mv | AT rzepczykszymon theotherfaceofinsulinoverdoseanditseffects AT dolinskakaczmarekklaudia theotherfaceofinsulinoverdoseanditseffects AT uruskaaleksandra theotherfaceofinsulinoverdoseanditseffects AT zabaczesław theotherfaceofinsulinoverdoseanditseffects AT rzepczykszymon otherfaceofinsulinoverdoseanditseffects AT dolinskakaczmarekklaudia otherfaceofinsulinoverdoseanditseffects AT uruskaaleksandra otherfaceofinsulinoverdoseanditseffects AT zabaczesław otherfaceofinsulinoverdoseanditseffects |